Moderna (NASDAQ: MRNA) holder Stephen Hoge plans 53,336-share sale

Rhea-AI Filing Summary

Stephen Hoge filed a notice for a proposed sale of up to 53,336 shares of Moderna common stock. The shares are tied to a stock option exercise dated 07/15/2026, with sales planned through Fidelity Brokerage Services LLC on the NASDAQ market.

In the prior three months, Hoge sold 53,336 shares on 05/15/2026 for a value of 2,581,462.40 and another 53,336 shares on 06/15/2026 for a value of 2,739,870.32.

Key Figures

Common shares proposed for sale: 53336 Shares sold 05/15/2026: 53336 Value of 05/15/2026 sale: 2581462.40 +2 more

5 metrics

Common shares proposed for sale 53336 Number of common shares in proposed sale tied to stock option exercise on 07/15/2026

Shares sold 05/15/2026 53336 Common shares sold by Stephen Hoge on 05/15/2026

Value of 05/15/2026 sale 2581462.40 Value associated with the 05/15/2026 common share sale

Shares sold 06/15/2026 53336 Common shares sold by Stephen Hoge on 06/15/2026

Value of 06/15/2026 sale 2739870.32 Value associated with the 06/15/2026 common share sale

Key Terms

Stock Option Exercise, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Stock Option Exercise financial

"Common | 07/15/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/15/2026 - 10:22 AM Accepted by SEC EDGAR 07/15/2026 - 10:22 AM Learn about SEC filing dates

FAQ

What stock sale is disclosed for MRNA in this Form 144 notice?

The filing describes a proposed sale of up to 53,336 Moderna common shares. These shares are linked to a stock option exercise dated 07/15/2026, with the planned sale routed through Fidelity Brokerage Services LLC on the NASDAQ market.

Who is the reporting person in the MRNA Form 144 filing?

The notice lists Stephen Hoge as the person proposing to sell Moderna common shares. His address is given as 325 Binney Street, Cambridge, MA 02142, and he is associated with the recent and proposed transactions in the company’s common stock.

How many MRNA shares has Stephen Hoge sold in the past three months?

Stephen Hoge sold 53,336 Moderna common shares on 05/15/2026 and another 53,336 shares on 06/15/2026. The respective values reported for these transactions are 2,581,462.40 and 2,739,870.32 over the three-month look-back period.

When is the proposed MRNA share sale expected to take place?

The proposed sale of 53,336 Moderna common shares is tied to a stock option exercise dated 07/15/2026. This date appears both in the securities information section and in the securities-to-be-sold details as the key reference for the planned transaction.

Are the MRNA shares in this filing related to stock options?

Yes. The securities-to-be-sold section identifies the transaction type as a Stock Option Exercise. The proposed sale of 53,336 Moderna common shares on 07/15/2026 is therefore connected to the exercise of stock options, with consideration specified as cash.

Through which broker and market will the MRNA shares be sold?

The filing lists Fidelity Brokerage Services LLC as the broker for the transaction. The common shares of Moderna referenced in the notice are to be sold on the NASDAQ market, as indicated in the securities information section of the document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	53336	3605513.60	396786259	07/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Stock Option Exercise	Issuer			53336	07/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	05/15/2026	53336	2581462.40
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	06/15/2026	53336	2739870.32

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)